Early diagnosis of eye disease with better retinal imaging

Article

Collaborative research has led to the development of an adaptive optics-optical coherence tomography (AO-OCT) system that allows ophthalmologists to see the eye's retina at the individual level.

Collaborative research has led to the development of an adaptive optics-optical coherence tomography (AO-OCT) system that allows ophthalmologists to see the eye's retina at the individual level.

Researchers at the Lawrence Livermore National Lab (LLNL), the Indiana University School of Optometry, Boston Micromachines and the University of California, Davis have built three AO-OCT instruments with the help of the National Eye Institute. These devices provide non-invasive, ultra-high resolution, three-dimensional volumetric retinal images for ophthalmologists and optometrists to view the cellular level structure in the human retina. This capability is expected to allow doctors to diagnose retinal diseases early and follow their progression as well as track the progress of genetic therapies that reverse the diseases.

Using the same principles that allow astronomers to view distant objects the device reportedly represents a revolutionary advancement over current instruments.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.